ATHE
Alterity Therapeutics
ATHE
ATHE
18 hedge funds and large institutions have $1M invested in Alterity Therapeutics in 2025 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Holders
18
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.74K | |
| 2 | +$3.02K | |
| 3 | +$153 | |
| 4 |
CA
CoreCap Advisors
Southfield,
Michigan
|
+$80 |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$38 |
Top Sellers
| 1 | -$20.4K | |
| 2 | -$19.1K | |
| 3 | -$2.43K | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
-$1.53K |
| 5 |
EWA
EverSource Wealth Advisors
Birmingham,
Alabama
|
-$666 |
